Activation of ras proto-oncogenes occurs frequently in vivo in chemica
lly induced rodent tumours, including rat hepatomas induced by aflatox
in B-1. This study examines the in vitro activation of a human ms gene
by this mycotoxin, A plasmid containing the human Ha-ms proto-oncogen
e, together with a neomycin resistance gene (pECneo), was incubated in
vitro with a microsomal system generating aflatoxin B-1 8,9-epoxide,
Subsequent transfection of the plasmid into mouse NIH 3T3 fibroblasts,
followed by G418 selection and s.c. injection of surviving cells into
immunodeficient mice demonstrated that the proto-oncogene had acquire
d transforming capacity, Although a single tumour resulted from simila
r treatment of incubated unconjugated plasmid, no tumours were produce
d by a secondary round of transfections using DNA from this tumour, Se
lective PCR amplification of the human Ha-ras gene in extracted tumour
DNA followed by sequencing demonstrated the presence of G-->T transve
rsions either at the first or middle base of codon 12 in tumours resul
ting from transfection with the aflatoxin-B-1-modified pECneo plasmid,
but this was not detected in the single tumour resulting from transfe
ction with the unmodified plasmid, Thus, although a mutation in the Ha
-ras gene has not been reported for human primary hepatomas occurring
in aflatoxin-exposed populations, metabolically activated aflatoxin B-
1 is capable of mutating this proto-oncogene to its oncogenic form in
vitro, No mutations were observed in codon 61. It appears that, in con
trast to the frequently reported G-->T transversions in codon 249 of t
he p53 gene in primary hepatomas in aflatoxin-exposed humans, the fail
ure to detect Ha-ms mutations in these tumours is not due to an inabil
ity of aflatoxin B-1 to activate this protooncogene, The G-->T transve
rsions observed in this study contrast with the most frequent aflatoxi
n B-1 in vivo induced mutations, G-->A transitions in the rat Ki-ras g
ene, Possible mechanisms for these differences are discussed.